“…Cell-mediated immunity is the main defense against CMV disease, including CD4 T helper cells and interferon gamma (IFN-γ) and interleukin 2 (IL-2) production, CD8 T cell-mediated cytolytic activity, as well as NK cell cytotoxicity. As inadequate immune response of CD4 T cells is a major factor responsible for lack of immune control of CMV infection, therefore, cytomegalovirus is considered to be a major pathogen in severely immunocompromised individuals as infants with SCID [ 8 ] and children with secondary immunodeficiencies, such as recipients of hematopoietic cell transplantation [ 9 , 10 ]. Significant morbidity and mortality in immunodeficient hosts may result from a primary, congenital or acquired infection, occur as a consequence of reactivation of the latent virus, or infection with a new CMV strain.…”